The PGIM Jennison Health Sciences Fund lost value, underperforming its benchmark Index during the Q1 of 2025. Click here to read the full commentary.

The Healthcare Select Sector SPDR Fund ETF is a sector ETF offering exposure to large-cap U.S. healthcare companies. Learn more about XLV here.

Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.

California-based clinical-stage biotech Juvena Therapeutics has entered a global licensing and multi-target research ...

However, considering it hovered near bear market territory a few weeks ago, things aren't so bad. Stocks might not be out of ...

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...